Alt Text
Office of Neuroscience Research > WUSTL Neuroscience News > NIH Weekly Funding Opportunities, Notices: May 18, 2018

NIH Weekly Funding Opportunities, Notices: May 18, 2018



Notices
Requests for Applications

     

  • Collaborative Network to Advance Deprescribing Research for Older Adults with Multiple Chronic Conditions (R24 Clinical Trial Optional)
    (RFA-AG-19-005)
    National Institute on Aging
    Application Receipt Date(s): October 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U19)
    (RFA-FD-18-025)
    Food and Drug Administration
    Application Receipt Date(s): July 18, 2018, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA. 

     

  • Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
    (RFA-HD-19-018)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): August 9, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers (UM1 Clinical Trial Not Allowed )
    (RFA-HL-19-009)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): August 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Limited Competition: Cardiothoracic Surgical Trials Network (CTSN) Data Coordinating Center (U01 Clinical Trial Required)
    (RFA-HL-19-010)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): August 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 - Clinical Trial Optional)
    (RFA-HL-19-017)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): July 27, 2018; July 9, 2019; July 9, 2020, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
    (RFA-HL-19-018)
    National Heart, Lung, and Blood Institute
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): July 27, 2018; July 9, 2019; July 9, 2020, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trial Not Allowed)
    (RFA-NS-18-029)
    National Institute of Neurological Disorders and Stroke
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    Office of Behavioral and Social Science Research
    Office of Research on Women's Health
    Application Receipt Date(s): July 23, 2018 and June 10, 2019 by 5:00 PM local time of applicant organization. Alltypes of non-AIDS applicationsallowed for this funding opportunity announcement are due on this date. 

     

  • Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
    (RFA-OD-18-005)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
    (RFA-OD-18-006)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    Application Receipt Date(s): July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
    (RFA-OD-18-007)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Late applications will be accepted for this Funding Opportunity Annoucement Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)
    (RFA-OD-18-008)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    Application Receipt Date(s): July 19, 2018, November 8, 2018, July 19, 2019, November 8, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Late applications will be accepted for this Funding Opportunity Announcement. 
Program Announcements

     

  • Exposure Analysis Services for the Environmental Influences on Child Health Outcomes (ECHO) Program (Admin Supp - Clinical Trial Not Allowed)
    (PA-18-783)
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): June 15, 2018, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed)
    (PA-18-784)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Wearable Alcohol Biosensors (STTR) (R41/R42- Clinical Trial Optional)
    (PA-18-785)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Wearable Alcohol Biosensors (SBIR) (R43/R44- Clinical Trial Optional)
    (PA-18-786)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed)
    (PAR-18-787)
    National Institute of Dental and Craniofacial Research
    National Cancer Institute
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Precision Imaging of Oral Lesions (R21-Clinical Trial Not Allowed)
    (PAR-18-788)
    National Institute of Dental and Craniofacial Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed)
    (PAR-18-789)
    National Institute on Drug Abuse
    Application Receipt Date(s): August 21, 2018, March 19, 2019; August 21, 2019, March 19, 2020; August 21, 2020, March 19, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.